APO Research

APO RESEARCH · REPORT

Computational Biology Platform

Selected research

Market Analysis & Forecast

Global Computational Biology Platform Market Analysis and Forecast 2026-2032

Market perspective

The global Computational Biology Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Computational Biology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Computational Biology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Computational Biology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Computational Biology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Computational Biology Platform include Saturn Cloud, Terra, Lamin, DNAnexus, Seven Bridges, Illumina, LatchBio, Lifebit and Dockstore, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Computational Biology Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Computational Biology Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Computational Biology Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Computational Biology Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Computational Biology Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Computational Biology Platform revenue, projected growth trends, production technology, application and end-user industry.

Computational Biology Platform Segment by Company

Saturn Cloud

Terra

Lamin

DNAnexus

Seven Bridges

Illumina

LatchBio

Lifebit

Dockstore

BC Platforms

Deep Origin

Biodonostia HRI

PLOS

CD ComputaBio

Cellworks

Basque Digital Innovation HUB (BDIH)

Pluto Bioinformatics

Computational Biology Platform Segment by Type

Cloud Based

On-Premises

Computational Biology Platform Segment by Application

Large Enterprises

SMEs

Computational Biology Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Biology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computational Biology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Biology Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Computational Biology Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Computational Biology Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computational Biology Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Computational Biology Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud Based Major Player Table 3. On-Premises Major Player Table 4. Global Computational Biology Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Large Enterprises Major Player Table 6. SMEs Major Player Table 7. Computational Biology Platform Industry Trends Table 8. Computational Biology Platform Industry Drivers Table 9. Computational Biology Platform Industry Opportunities and Challenges Table 10. Computational Biology Platform Industry Restraints Table 11. Global Computational Biology Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Computational Biology Platform Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Computational Biology Platform Market Share by Region (2021-2026) Table 14. Global Computational Biology Platform Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Computational Biology Platform Market Share by Region (2027-2032) Table 16. Global Computational Biology Platform Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Computational Biology Platform Revenue Market Share by Players (2021-2026) Table 18. Global Computational Biology Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Computational Biology Platform Key Players Headquarters & Area Served Table 20. Global Computational Biology Platform Players, Product Type & Application Table 21. Global Computational Biology Platform Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Computational Biology Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Computational Biology Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Computational Biology Platform Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Computational Biology Platform Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Computational Biology Platform Revenue Market Share by Type (2021-2026) Table 28. Global Computational Biology Platform Revenue Market Share by Type (2027-2032) Table 29. Global Computational Biology Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Computational Biology Platform Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Computational Biology Platform Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Computational Biology Platform Revenue Market Share by Application (2021-2026) Table 33. Global Computational Biology Platform Revenue Market Share by Application (2027-2032) Table 34. Saturn Cloud Company Information Table 35. Saturn Cloud Business Overview Table 36. Saturn Cloud Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Saturn Cloud Computational Biology Platform Product Portfolio Table 38. Saturn Cloud Recent Development Table 39. Terra Company Information Table 40. Terra Business Overview Table 41. Terra Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Terra Computational Biology Platform Product Portfolio Table 43. Terra Recent Development Table 44. Lamin Company Information Table 45. Lamin Business Overview Table 46. Lamin Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Lamin Computational Biology Platform Product Portfolio Table 48. Lamin Recent Development Table 49. DNAnexus Company Information Table 50. DNAnexus Business Overview Table 51. DNAnexus Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. DNAnexus Computational Biology Platform Product Portfolio Table 53. DNAnexus Recent Development Table 54. Seven Bridges Company Information Table 55. Seven Bridges Business Overview Table 56. Seven Bridges Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Seven Bridges Computational Biology Platform Product Portfolio Table 58. Seven Bridges Recent Development Table 59. Illumina Company Information Table 60. Illumina Business Overview Table 61. Illumina Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Illumina Computational Biology Platform Product Portfolio Table 63. Illumina Recent Development Table 64. LatchBio Company Information Table 65. LatchBio Business Overview Table 66. LatchBio Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. LatchBio Computational Biology Platform Product Portfolio Table 68. LatchBio Recent Development Table 69. Lifebit Company Information Table 70. Lifebit Business Overview Table 71. Lifebit Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Lifebit Computational Biology Platform Product Portfolio Table 73. Lifebit Recent Development Table 74. Dockstore Company Information Table 75. Dockstore Business Overview Table 76. Dockstore Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Dockstore Computational Biology Platform Product Portfolio Table 78. Dockstore Recent Development Table 79. BC Platforms Company Information Table 80. BC Platforms Business Overview Table 81. BC Platforms Computational Biology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. BC Platforms Computational Biology Platform Product Portfolio Table 83. BC Platforms Recent Development Table 84. Deep Origin Company Information Table 85. Deep Origin Business Overview Table 86. Deep Origin Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Deep Origin Computational Biology Platform Product Portfolio Table 88. Deep Origin Recent Development Table 89. Biodonostia HRI Company Information Table 90. Biodonostia HRI Business Overview Table 91. Biodonostia HRI Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Biodonostia HRI Computational Biology Platform Product Portfolio Table 93. Biodonostia HRI Recent Development Table 94. PLOS Company Information Table 95. PLOS Business Overview Table 96. PLOS Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. PLOS Computational Biology Platform Product Portfolio Table 98. PLOS Recent Development Table 99. CD ComputaBio Company Information Table 100. CD ComputaBio Business Overview Table 101. CD ComputaBio Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. CD ComputaBio Computational Biology Platform Product Portfolio Table 103. CD ComputaBio Recent Development Table 104. Cellworks Company Information Table 105. Cellworks Business Overview Table 106. Cellworks Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Cellworks Computational Biology Platform Product Portfolio Table 108. Cellworks Recent Development Table 109. Basque Digital Innovation HUB (BDIH) Company Information Table 110. Basque Digital Innovation HUB (BDIH) Business Overview Table 111. Basque Digital Innovation HUB (BDIH) Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Basque Digital Innovation HUB (BDIH) Computational Biology Platform Product Portfolio Table 113. Basque Digital Innovation HUB (BDIH) Recent Development Table 114. Pluto Bioinformatics Company Information Table 115. Pluto Bioinformatics Business Overview Table 116. Pluto Bioinformatics Computational Biology Platform Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Pluto Bioinformatics Computational Biology Platform Product Portfolio Table 118. Pluto Bioinformatics Recent Development Table 119. North America Computational Biology Platform Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Computational Biology Platform Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Computational Biology Platform Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Computational Biology Platform Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Computational Biology Platform Revenue by Country (2021-2026) & (US$ Million) Table 125. North America Computational Biology Platform Revenue by Country (US$ Million) & (2027-2032) Table 126. Europe Computational Biology Platform Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Computational Biology Platform Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Computational Biology Platform Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Computational Biology Platform Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Computational Biology Platform Revenue by Country (2021-2026) & (US$ Million) Table 132. Europe Computational Biology Platform Revenue by Country (US$ Million) & (2027-2032) Table 133. China Computational Biology Platform Revenue by Type (2021-2026) & (US$ Million) Table 134. China Computational Biology Platform Revenue by Type (2027-2032) & (US$ Million) Table 135. China Computational Biology Platform Revenue by Application (2021-2026) & (US$ Million) Table 136. China Computational Biology Platform Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Computational Biology Platform Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Computational Biology Platform Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Computational Biology Platform Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Computational Biology Platform Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Computational Biology Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Computational Biology Platform Revenue by Region (US$ Million) & (2021-2026) Table 143. Asia Computational Biology Platform Revenue by Region (US$ Million) & (2027-2032) Table 144. SAMEA Computational Biology Platform Revenue by Type (2021-2026) & (US$ Million) Table 145. SAMEA Computational Biology Platform Revenue by Type (2027-2032) & (US$ Million) Table 146. SAMEA Computational Biology Platform Revenue by Application (2021-2026) & (US$ Million) Table 147. SAMEA Computational Biology Platform Revenue by Application (2027-2032) & (US$ Million) Table 148. SAMEA Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. SAMEA Computational Biology Platform Revenue by Country (2021-2026) & (US$ Million) Table 150. SAMEA Computational Biology Platform Revenue by Country (US$ Million) & (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Computational Biology Platform Image Figure 2. Global Computational Biology Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computational Biology Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud Based Image Figure 5. On-Premises Image Figure 6. Global Computational Biology Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Computational Biology Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Large Enterprises Image Figure 9. SMEs Image Figure 10. Global Computational Biology Platform Market Size (US$ Million) & (2021-2032) Figure 11. Global Computational Biology Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Computational Biology Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Computational Biology Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Computational Biology Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Computational Biology Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Computational Biology Platform Revenue Market Share by Type (2021-2032) Figure 18. Global Computational Biology Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Computational Biology Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Computational Biology Platform Revenue Market Share by Application (2021-2032) Figure 21. North America Computational Biology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Computational Biology Platform Revenue Share by Type (2021-2032) Figure 23. North America Computational Biology Platform Revenue Share by Application (2021-2032) Figure 24. North America Computational Biology Platform Revenue Share by Country (2021-2032) Figure 25. United States Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Computational Biology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Computational Biology Platform Revenue Share by Type (2021-2032) Figure 30. Europe Computational Biology Platform Revenue Share by Application (2021-2032) Figure 31. Europe Computational Biology Platform Revenue Share by Country (2021-2032) Figure 32. Germany Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Computational Biology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Computational Biology Platform Revenue Share by Type (2021-2032) Figure 42. China Computational Biology Platform Revenue Share by Application (2021-2032) Figure 43. Asia Computational Biology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Computational Biology Platform Revenue Share by Type (2021-2032) Figure 45. Asia Computational Biology Platform Revenue Share by Application (2021-2032) Figure 46. Asia Computational Biology Platform Revenue Share by Region (2021-2032) Figure 47. Japan Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Computational Biology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Computational Biology Platform Revenue Share by Type (2021-2032) Figure 55. SAMEA Computational Biology Platform Revenue Share by Application (2021-2032) Figure 56. SAMEA Computational Biology Platform Revenue Share by Country (2021-2032) Figure 57. Brazil Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Computational Biology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On-Premises
Applications
  • Large Enterprises
  • SMEs
Companies covered
  • Saturn Cloud
  • Terra
  • Lamin
  • DNAnexus
  • Seven Bridges
  • Illumina
  • LatchBio
  • Lifebit
  • Dockstore
  • BC Platforms
  • Deep Origin
  • Biodonostia HRI
  • PLOS
  • CD ComputaBio
  • Cellworks
  • Basque Digital Innovation HUB (BDIH)
  • Pluto Bioinformatics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Computational Biology Platform Market by Type
  3. 1.2.1 Global Computational Biology Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud Based
  5. 1.2.3 On-Premises
  6. 1.3 Computational Biology Platform Market by Application
  7. 1.3.1 Global Computational Biology Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Large Enterprises
  9. 1.3.3 SMEs
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Computational Biology Platform Market Dynamics
  1. 2.1 Computational Biology Platform Industry Trends
  2. 2.2 Computational Biology Platform Industry Drivers
  3. 2.3 Computational Biology Platform Industry Opportunities and Challenges
  4. 2.4 Computational Biology Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Computational Biology Platform Market Perspective (2021-2032)
  2. 3.2 Global Computational Biology Platform Growth Trends by Region
  3. 3.2.1 Global Computational Biology Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Computational Biology Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Computational Biology Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Computational Biology Platform Revenue by Players
  2. 4.1.1 Global Computational Biology Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Computational Biology Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Computational Biology Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Computational Biology Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Computational Biology Platform Key Players Headquarters & Area Served
  7. 4.4 Global Computational Biology Platform Players, Product Type & Application
  8. 4.5 Global Computational Biology Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Computational Biology Platform Market CR5 and HHI
  11. 4.6.3 2025 Computational Biology Platform Tier 1, Tier 2, and Tier 3
5 Computational Biology Platform Market Size by Type
  1. 5.1 Global Computational Biology Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Computational Biology Platform Revenue by Type (2021-2032)
  3. 5.3 Global Computational Biology Platform Revenue Market Share by Type (2021-2032)
6 Computational Biology Platform Market Size by Application
  1. 6.1 Global Computational Biology Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Computational Biology Platform Revenue by Application (2021-2032)
  3. 6.3 Global Computational Biology Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Saturn Cloud
  2. 7.1.1 Saturn Cloud Company Information
  3. 7.1.2 Saturn Cloud Business Overview
  4. 7.1.3 Saturn Cloud Computational Biology Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Saturn Cloud Computational Biology Platform Product Portfolio
  6. 7.1.5 Saturn Cloud Recent Developments
  7. 7.2 Terra
  8. 7.2.1 Terra Company Information
  9. 7.2.2 Terra Business Overview
  10. 7.2.3 Terra Computational Biology Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Terra Computational Biology Platform Product Portfolio
  12. 7.2.5 Terra Recent Developments
  13. 7.3 Lamin
  14. 7.3.1 Lamin Company Information
  15. 7.3.2 Lamin Business Overview
  16. 7.3.3 Lamin Computational Biology Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lamin Computational Biology Platform Product Portfolio
  18. 7.3.5 Lamin Recent Developments
  19. 7.4 DNAnexus
  20. 7.4.1 DNAnexus Company Information
  21. 7.4.2 DNAnexus Business Overview
  22. 7.4.3 DNAnexus Computational Biology Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DNAnexus Computational Biology Platform Product Portfolio
  24. 7.4.5 DNAnexus Recent Developments
  25. 7.5 Seven Bridges
  26. 7.5.1 Seven Bridges Company Information
  27. 7.5.2 Seven Bridges Business Overview
  28. 7.5.3 Seven Bridges Computational Biology Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Seven Bridges Computational Biology Platform Product Portfolio
  30. 7.5.5 Seven Bridges Recent Developments
  31. 7.6 Illumina
  32. 7.6.1 Illumina Company Information
  33. 7.6.2 Illumina Business Overview
  34. 7.6.3 Illumina Computational Biology Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Illumina Computational Biology Platform Product Portfolio
  36. 7.6.5 Illumina Recent Developments
  37. 7.7 LatchBio
  38. 7.7.1 LatchBio Company Information
  39. 7.7.2 LatchBio Business Overview
  40. 7.7.3 LatchBio Computational Biology Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 LatchBio Computational Biology Platform Product Portfolio
  42. 7.7.5 LatchBio Recent Developments
  43. 7.8 Lifebit
  44. 7.8.1 Lifebit Company Information
  45. 7.8.2 Lifebit Business Overview
  46. 7.8.3 Lifebit Computational Biology Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lifebit Computational Biology Platform Product Portfolio
  48. 7.8.5 Lifebit Recent Developments
  49. 7.9 Dockstore
  50. 7.9.1 Dockstore Company Information
  51. 7.9.2 Dockstore Business Overview
  52. 7.9.3 Dockstore Computational Biology Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Dockstore Computational Biology Platform Product Portfolio
  54. 7.9.5 Dockstore Recent Developments
  55. 7.10 BC Platforms
  56. 7.10.1 BC Platforms Company Information
  57. 7.10.2 BC Platforms Business Overview
  58. 7.10.3 BC Platforms Computational Biology Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BC Platforms Computational Biology Platform Product Portfolio
  60. 7.10.5 BC Platforms Recent Developments
  61. 7.11 Deep Origin
  62. 7.11.1 Deep Origin Company Information
  63. 7.11.2 Deep Origin Business Overview
  64. 7.11.3 Deep Origin Computational Biology Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Deep Origin Computational Biology Platform Product Portfolio
  66. 7.11.5 Deep Origin Recent Developments
  67. 7.12 Biodonostia HRI
  68. 7.12.1 Biodonostia HRI Company Information
  69. 7.12.2 Biodonostia HRI Business Overview
  70. 7.12.3 Biodonostia HRI Computational Biology Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biodonostia HRI Computational Biology Platform Product Portfolio
  72. 7.12.5 Biodonostia HRI Recent Developments
  73. 7.13 PLOS
  74. 7.13.1 PLOS Company Information
  75. 7.13.2 PLOS Business Overview
  76. 7.13.3 PLOS Computational Biology Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 PLOS Computational Biology Platform Product Portfolio
  78. 7.13.5 PLOS Recent Developments
  79. 7.14 CD ComputaBio
  80. 7.14.1 CD ComputaBio Company Information
  81. 7.14.2 CD ComputaBio Business Overview
  82. 7.14.3 CD ComputaBio Computational Biology Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CD ComputaBio Computational Biology Platform Product Portfolio
  84. 7.14.5 CD ComputaBio Recent Developments
  85. 7.15 Cellworks
  86. 7.15.1 Cellworks Company Information
  87. 7.15.2 Cellworks Business Overview
  88. 7.15.3 Cellworks Computational Biology Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Cellworks Computational Biology Platform Product Portfolio
  90. 7.15.5 Cellworks Recent Developments
  91. 7.16 Basque Digital Innovation HUB (BDIH)
  92. 7.16.1 Basque Digital Innovation HUB (BDIH) Company Information
  93. 7.16.2 Basque Digital Innovation HUB (BDIH) Business Overview
  94. 7.16.3 Basque Digital Innovation HUB (BDIH) Computational Biology Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Basque Digital Innovation HUB (BDIH) Computational Biology Platform Product Portfolio
  96. 7.16.5 Basque Digital Innovation HUB (BDIH) Recent Developments
  97. 7.17 Pluto Bioinformatics
  98. 7.17.1 Pluto Bioinformatics Company Information
  99. 7.17.2 Pluto Bioinformatics Business Overview
  100. 7.17.3 Pluto Bioinformatics Computational Biology Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Pluto Bioinformatics Computational Biology Platform Product Portfolio
  102. 7.17.5 Pluto Bioinformatics Recent Developments
8 North America
  1. 8.1 North America Computational Biology Platform Revenue (2021-2032)
  2. 8.2 North America Computational Biology Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Computational Biology Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Computational Biology Platform Revenue by Type (2027-2032)
  5. 8.3 North America Computational Biology Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Computational Biology Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Computational Biology Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Computational Biology Platform Revenue by Application (2027-2032)
  9. 8.5 North America Computational Biology Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Computational Biology Platform Revenue by Country
  11. 8.6.1 North America Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Computational Biology Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Computational Biology Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Computational Biology Platform Revenue (2021-2032)
  2. 9.2 Europe Computational Biology Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Computational Biology Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Computational Biology Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Computational Biology Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Computational Biology Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Computational Biology Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Computational Biology Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Computational Biology Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Computational Biology Platform Revenue by Country
  11. 9.6.1 Europe Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Computational Biology Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Computational Biology Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Computational Biology Platform Revenue (2021-2032)
  2. 10.2 China Computational Biology Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Computational Biology Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Computational Biology Platform Revenue by Type (2027-2032)
  5. 10.3 China Computational Biology Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Computational Biology Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Computational Biology Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Computational Biology Platform Revenue by Application (2027-2032)
  9. 10.5 China Computational Biology Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Computational Biology Platform Revenue (2021-2032)
  2. 11.2 Asia Computational Biology Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Computational Biology Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Computational Biology Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Computational Biology Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Computational Biology Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Computational Biology Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Computational Biology Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Computational Biology Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Computational Biology Platform Revenue by Country
  11. 11.6.1 Asia Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Computational Biology Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Computational Biology Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Computational Biology Platform Revenue (2021-2032)
  2. 12.2 SAMEA Computational Biology Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Computational Biology Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Computational Biology Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Computational Biology Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Computational Biology Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Computational Biology Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Computational Biology Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Computational Biology Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Computational Biology Platform Revenue by Country
  11. 12.6.1 SAMEA Computational Biology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Computational Biology Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Computational Biology Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research